MetaStat (MTST) Price & Analysis

3 Followers

MTST Stock Chart & Stats

$0.08

$0.00(0.00%)

At close: May 19 4:00 PM EDT

$0.08

$0.00(0.00%)

Day’s Range― - ―

52-Week Range$0.08 - $0.08

Previous CloseN/A

Volume20.00

Average Volume (3M)0.00

Market Cap

$5.88K

Enterprise Value$688.94K

Total Cash (Recent Filing)$316.93K

Total Debt (Recent Filing)$1.00M

Price to Earnings (P/E)―

Beta-71.70

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.58

Shares Outstanding5,877,000

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio0.52

Price to Book (P/B)-43.08

Price to Sales (P/S)2863.99

P/FCF Ratio-24.06

Enterprise Value/Market Cap117.23

Enterprise Value/Revenue29.57

Enterprise Value/Gross Profit29.57

Enterprise Value/Ebitda-0.20

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

MTST FAQ

What was MetaStat Inc’s price range in the past 12 months?

MetaStat Inc lowest stock price was $0.08 and its highest was $0.08 in the past 12 months.

What is MetaStat Inc’s market cap?

MetaStat Inc’s market cap is $5.88K.

When is MetaStat Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were MetaStat Inc’s earnings last quarter?

Currently, no data Available

Is MetaStat Inc overvalued?

According to Wall Street analysts MetaStat Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does MetaStat Inc pay dividends?

MetaStat Inc does not currently pay dividends.

What is MetaStat Inc’s EPS estimate?

MetaStat Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does MetaStat Inc have?

MetaStat Inc has 5,877,000 shares outstanding.

What happened to MetaStat Inc’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of MetaStat Inc?

Currently, no hedge funds are holding shares in MTST

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

MetaStat Inc

MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.